Impact of Minimal Residual Negativity using Next Generation Flow Cytometry on Outcomes in Light Chain Amyloidosis

We evaluated bone marrow minimal residual disease (MRD) negativity in 44 patients with light chain (AL) amyloidosis using next generation flow cytometry (sensitivity ≥ 1× 10(−5); median events analyzed: 8.7 million, range: 4.8 to 9.7 million). All patients underwent MRD testing in two years from sta...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Am J Hematol
Hoofdauteurs: Sidana, Surbhi, Muchtar, Eli, Sidiqi, M.Hasib, Jevremovic, Dragan, Dispenzieri, Angela, Gonsalves, Wilson, Buadi, Francis, Lacy, Martha Q., Hayman, Suzanne R., Kourelis, Taxiarchis, Kapoor, Prashant, Go, Ronald S., Warsame, Rahma, Leung, Nelson, Rajkumar, S.Vincent, Kyle, Robert A., Gertz, Morie A., Kumar, Shaji K.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2020
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8019396/
https://ncbi.nlm.nih.gov/pubmed/32010993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.25746
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items